Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Northcott

Showing results (171-180 of 223) with videos related to

Pageof 23
Sort By:
Nature|February 21, 2012
Clonal selection drives genetic divergence of metastatic medulloblastomaXiaochong Wu, Paul A Northcott, Adrian Dubuc, et al.
Cancer Cell|October 22, 2021
Serial assessment of measurable residual disease in medulloblastoma liquid biopsiesAnthony P Y Liu, Kyle S Smith, Rahul Kumar, et al.
Cancer Cell|August 16, 2011
Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymomaHendrik Witt, Stephen C Mack, Marina Ryzhova, et al.
Nature|January 28, 2016
Active medulloblastoma enhancers reveal subgroup-specific cellular originsCharles Y Lin, Serap Erkek, Yiai Tong, et al.
Cancer Cell|November 5, 2013
Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomasSebastian Bender, Yujie Tang, Anders M Lindroth, et al.
Neuro-Oncology|August 3, 2023
Mapping pediatric brain tumors to their origins in the developing cerebellumKonstantin Okonechnikov, Piyush Joshi, Mari Sepp, et al.
The Lancet. Oncology|May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trialGiles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.
Acta Neuropathologica|August 18, 2022
Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trialsAnthony P Y Liu, Sandeep K Dhanda, Tong Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)Amar Gajjar, Giles W Robinson, Kyle S Smith, et al.
Cell|May 28, 2013
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongationGabriel Leprivier, Marc Remke, Barak Rotblat, et al.
Pageof 23

Showing results (171-180 of 223) with videos related to

Sort By:
Pageof 23
Nature|February 21, 2012
Clonal selection drives genetic divergence of metastatic medulloblastomaXiaochong Wu, Paul A Northcott, Adrian Dubuc, et al.
Cancer Cell|October 22, 2021
Serial assessment of measurable residual disease in medulloblastoma liquid biopsiesAnthony P Y Liu, Kyle S Smith, Rahul Kumar, et al.
Cancer Cell|August 16, 2011
Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymomaHendrik Witt, Stephen C Mack, Marina Ryzhova, et al.
Nature|January 28, 2016
Active medulloblastoma enhancers reveal subgroup-specific cellular originsCharles Y Lin, Serap Erkek, Yiai Tong, et al.
Cancer Cell|November 5, 2013
Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomasSebastian Bender, Yujie Tang, Anders M Lindroth, et al.
Neuro-Oncology|August 3, 2023
Mapping pediatric brain tumors to their origins in the developing cerebellumKonstantin Okonechnikov, Piyush Joshi, Mari Sepp, et al.
The Lancet. Oncology|May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trialGiles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.
Acta Neuropathologica|August 18, 2022
Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trialsAnthony P Y Liu, Sandeep K Dhanda, Tong Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)Amar Gajjar, Giles W Robinson, Kyle S Smith, et al.
Cell|May 28, 2013
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongationGabriel Leprivier, Marc Remke, Barak Rotblat, et al.
Pageof 23